Stock Scorecard



Stock Summary for Phreesia Inc (PHR) - $16.55 as of 12/22/2025 2:51:02 PM EST

Total Score

12 out of 30

Safety Score

38 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for PHR

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PHR

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PHR

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PHR

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PHR (38 out of 100)

Stock Price Rating (Max of 10) 6
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 5
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for PHR

Phreesia Swings to Profit as Growth Accelerates and AccessOne Deal Lands 12/20/2025 7:08:00 AM
Phreesia swings to profit as growth accelerates and AccessOne deal lands 12/20/2025 7:08:00 AM
Phreesia Named to The Software Report’s “Top 50 Software Companies” for the Fourth Consecutive Year 12/18/2025 9:09:00 PM
Squarepoint Ops LLC Buys 71,553 Shares of Phreesia, Inc. $PHR 12/18/2025 11:09:00 AM
BMO Capital Sticks to Its Buy Rating for Phreesia (PHR) 12/18/2025 4:09:00 AM
Phreesia (PHR) Analyst Model Updated to Reflect Company's Latest Financial Guidance for 2026-2027 12/16/2025 1:08:00 PM
Phreesia (PHR) Receives Updated Price Target from Barclays | PHR Stock News 12/16/2025 1:08:00 PM
Piper Sandler recommends buying Doximity and Phreesia stock after pharma marketing event 12/16/2025 12:09:00 PM
Phreesia (PHR) Analyst Model Updated to Reflect Company’s Latest Financial Guidance for 2026-2027 12/16/2025 4:09:00 AM
Phreesia (PHR) Analyst Model Updated to Reflect Company’s Latest Financial Guidance for 2026-2027 12/15/2025 11:10:00 PM

Financial Details for PHR

Company Overview

Ticker PHR
Company Name Phreesia Inc
Country USA
Description Phreesia, Inc. is a premier provider of SaaS solutions and payment platforms specifically designed for the healthcare industry, primarily serving clients in the United States and Canada. Based in Raleigh, North Carolina, Phreesia employs cutting-edge technology to improve patient engagement and optimize operational workflows for healthcare providers. Its robust suite of solutions enables efficient patient check-in, streamlined data collection, and seamless payment processing, thereby enhancing administrative efficiency while elevating the overall patient experience. As healthcare moves toward more patient-centric models, Phreesia is well-positioned to empower organizations in achieving transformative improvements in care delivery and operational effectiveness.
Sector Name HEALTHCARE
Industry Name HEALTH INFORMATION SERVICES
Most Recent Quarter 10/31/2025
Next Earnings Date N/A

Stock Price History

Last Day Price 16.55
Price 4 Years Ago 41.66
Last Day Price Updated 12/22/2025 2:51:02 PM EST
Last Day Volume 1,198,834
Average Daily Volume 1,520,773
52-Week High 32.76
52-Week Low 15.41
Last Price to 52 Week Low 7.40%

Valuation Measures

Trailing PE N/A
Industry PE 216.63
Sector PE 53.39
5-Year Average PE -16.30
Free Cash Flow Ratio 9.40
Industry Free Cash Flow Ratio 49.47
Sector Free Cash Flow Ratio 33.77
Current Ratio Most Recent Quarter 2.44
Total Cash Per Share 1.76
Book Value Per Share Most Recent Quarter 5.32
Price to Book Ratio 3.12
Industry Price to Book Ratio 7.78
Sector Price to Book Ratio 49.15
Price to Sales Ratio Twelve Trailing Months 2.15
Industry Price to Sales Ratio Twelve Trailing Months 5.67
Sector Price to Sales Ratio Twelve Trailing Months 14.97
Analyst Buy Ratings 12
Analyst Strong Buy Ratings 5

Share Statistics

Total Shares Outstanding 60,287,000
Market Capitalization 997,749,850
Institutional Ownership 103.60%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 57.24%
Reported EPS 12 Trailing Months -0.09
Reported EPS Past Year 0.55
Reported EPS Prior Year -0.44
Net Income Twelve Trailing Months -5,379,000
Net Income Past Year -58,527,000
Net Income Prior Year -136,885,000
Quarterly Revenue Growth YOY 45.70%
5-Year Revenue Growth 27.46%
Operating Margin Twelve Trailing Months -46.70%

Balance Sheet

Total Cash Most Recent Quarter 106,371,000
Total Cash Past Year 84,220,000
Total Cash Prior Year 87,520,000
Net Cash Position Most Recent Quarter 103,018,000
Net Cash Position Past Year 83,501,000
Long Term Debt Past Year 719,000
Long Term Debt Prior Year 2,049,000
Total Debt Most Recent Quarter 3,353,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 0.99
Total Stockholder Equity Past Year 264,808,000
Total Stockholder Equity Prior Year 251,449,000
Total Stockholder Equity Most Recent Quarter 320,329,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 41,920,000
Free Cash Flow Per Share Twelve Trailing Months 0.70
Free Cash Flow Past Year 8,292,000
Free Cash Flow Prior Year -57,475,000

Options

Put/Call Ratio 0.72
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -1.49
MACD Signal -1.26
20-Day Bollinger Lower Band 15.53
20-Day Bollinger Middle Band 23.41
20-Day Bollinger Upper Band 31.28
Beta 0.64
RSI 29.17
50-Day SMA 25.40
150-Day SMA 0.00
200-Day SMA 25.22

System

Modified 12/20/2025 7:01:49 AM EST